UTRADE brought to you by UOB Kay Hian

Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2022

JAN

FEB

2021222324252627282930310102030405060708
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price(HKD) BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
2121AINNOVATION 17/01/202220/01/2022 27/01/2022 26.3027.30 100 1.68% 19/01/2022

UBS

CICC

China Renaissance

Day 1:<1.44x

Day 2:<3.70x

Day 3:<6.1x

Planned IPOs *
Huitongda Passed PHIP on 9 Jan N/A N/A N/A N/A N/A

CICC*

Citi*

China Renaissance*

-
Everjoy Services Passed PHIP 23 Dec N/A N/A N/A N/A N/A

HUATAI*

-
Bioer Technology Passed PHIP on 19 Dec N/A N/A N/A N/A N/A

CICC*

-
China Tourism Group Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

CICC*

UBS*

-
Shinsun Lifestyle Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

ABCI*

CCBI*

-
Horizon Construction Passed PHIP on 15 Nov N/A N/A N/A N/A N/A

Huatai*

Citi*

CMBI*

DBS*

-
WEILONG Delicious Passed PHIP on 14 Nov 2022* N/A N/A N/A N/A

Morgan Stanley*

CICC*

UBS*

-
ZOINA Service Passed PHIP on 12 Nov N/A N/A N/A N/A N/A

CCBI*

-
TI Cloud Passed PHIP on 15 Dec N/A N/A N/A N/A N/A

CICC*

-
IQIYI N/A N/A N/A N/A N/A N/A

N/A

-
FUTU N/A N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

-
Ximalaya N/A N/A N/A N/A N/A N/A

N/A

-
Novotech Health Passed PHIP on 5 Sep N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

-
AInnovation Application Submitted* N/A N/A N/A N/A N/A

UBS*

CICC*

China Renaissance*

-
Imeik Technology Dev N/A N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

-
Edding Group Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

Credit Suisse*

-
eBeauty Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

CITIC*

Credit Suisse*

-
Chief Group Application Submitted* N/A N/A N/A N/A N/A

BOCOM*

-
Konew Financial N/A N/A N/A N/A N/A N/A

CCBI*

-
LexinFintech N/A N/A N/A N/A N/A N/A

N/A

-
Top Glove N/A 2022 Q1* N/A N/A N/A N/A

CICC*

-
Fangzhi Group Application Submitted* N/A N/A N/A N/A N/A

CCBI*

-
Wanda Group N/A N/A N/A N/A N/A N/A

N/A

-
DRC Bank N/A N/A N/A N/A N/A N/A

CMS*

CMBI*

ABCI*

ICBC*

-
Hanyu Medical Passed PHIP on 13 Sep N/A N/A N/A N/A N/A

CITIC*

Citi*

-
XiaoDian N/A N/A N/A N/A N/A N/A

N/A

-
Medbanks N/A N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

-
NIO N/A N/A N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

-
YiSheng Biopharma Application Submitted* N/A N/A N/A N/A N/A

Morgan Stanley*

Haitong*

-
Novotech N/A N/A N/A N/A N/A N/A

N/A

-
ECARX N/A N/A N/A N/A N/A N/A

Morgan Stanley*

UBS*

-
Betta Pharmaceuticals Passed PHIP on 30 May N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

-
Recbio N/A 2022* N/A N/A N/A N/A

Morgan Stanley*

CMBI*

CITIC*

-
DIDA CHUXING Application Submitted* N/A N/A N/A N/A N/A

Haitong*

Nomura*

-
DiDi N/A 2022* N/A N/A N/A N/A

Goldman Sachs*

-

# Terms and Conditions Apply

*Market News

:UOB Kay Hian (UOBKH) is one of the participants